To elucidate the relative impact of Alzheimer’s tau pathology on clinical phenotype, we compared the mean density of tau inclusions in PPA-AD cases with stereologic data from five participants who carried an antemortem clinical diagnosis of DAT-AD. This evidence concerns the gene MAPT and Alzheimer disease.